Abstract
NAFLD is now relevant to defective antimicrobial drug
metabolism in diabetes and neurodegenerative diseases.
The NAFLD epidemic is expected by the year 2050 to
effect between 20-30% of the global population. Excessive
systemic administration of antibiotic use with NAFLD should
be avoided to prevent excessive LPS release with antibiotic
use associated with mitophagy in NAFLD and multisystem
diseases that include diabetes, neurodegenerative diseases and
soft tissue diseases such as diabetic foot ulcer.
metabolism in diabetes and neurodegenerative diseases.
The NAFLD epidemic is expected by the year 2050 to
effect between 20-30% of the global population. Excessive
systemic administration of antibiotic use with NAFLD should
be avoided to prevent excessive LPS release with antibiotic
use associated with mitophagy in NAFLD and multisystem
diseases that include diabetes, neurodegenerative diseases and
soft tissue diseases such as diabetic foot ulcer.
| Original language | English |
|---|---|
| Journal | Journal of Diabetes and Clinical Studies |
| Volume | 2 |
| Issue number | 1 |
| Publication status | Published - 6 Nov 2018 |
